Showing results (1-10 of 81) with videos related to
Sort By:
Pageof 9
Breast Cancer Research : BCR|June 30, 2010
Managing bone mineral density with oral bisphosphonate therapy in women with breast cancer receiving adjuvant aromatase inhibitionCatherine Van PoznakCancer Investigation|February 10, 2006
The phenomenon of osteonecrosis of the jaw in patients with metastatic breast cancerCatherine Van PoznakJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 30, 2007
Significance and impact of bisphosphonate-induced acute phase responsesKarin Olson, Catherine Van PoznakOncology (Williston Park, N.Y.)|September 22, 2006
Osteonecrosis of the jaw in cancer patients receiving IV bisphosphonatesCatherine Van Poznak, Cherry EstiloCurrent Osteoporosis Reports|June 30, 2021
Updates in Management of Bone Metastatic Disease in Primary Solid Tumors with Systemic TherapiesVirginia Falvello, Catherine Van PoznakCurrent Oncology Reports|February 9, 2006
Bone integrity and bone metastases in breast cancerCatherine Van Poznak, Cristina NadalCurrent Osteoporosis Reports|June 9, 2023
Checkpoint Inhibitors in Bone Metastatic Disease in Solid TumorsVictoria Wytiaz, Catherine Van PoznakCancer|June 22, 2005
Clinical management of osteoporosis in women with a history of breast carcinomaCatherine Van Poznak, Nicholas P SauterCancer Investigation|November 22, 2002
Critical review of current treatment strategies for advanced hormone insensitive breast cancerCatherine Van Poznak, Andrew D SeidmanAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Therapeutic Bone-Modifying Agents in the Nonmetastatic Breast Cancer Setting: The Controversy and a Value AssessmentMichael Gnant, Catherine Van Poznak, Lowell SchnipperPageof 9